Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: THE INSTITUTE FOR CANCER RESEARCH
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2016-09-20 to 2022-06-19
Current total value of award: $989435
Description: PREVENT: TO TITLE: TARGETING THE IL SIGNAL PATHWAY AS CHEMOPREVENTION THERAPY FOR HIGH RISK MALIGNANT MESOTHELIOMA POPULATIONS